Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04489524 · ClinicalTrials.gov registry record · NA

Smoking Cessation in NYC

A NA study of Smoking Cessation, sponsored by Temple University.

Completed
Registry status
NA
Development phase
139
Enrollment target
1
Study location

NCT04489524 is a NA study of Smoking Cessation that has completed, run by Temple University. The registered enrollment target is 139 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04489524, a NA study of Smoking Cessation, has completed, sponsored by Temple University.

COMPLETED
Registry status
NA
Development phase
139 participants
Enrollment target
1
Study location

Study Summary

The investigators tested the feasibility of a culturally and linguistically sensitive smoking cessation program with combined counseling and pharmacological components for Chinese smokers in New York City; identified factors and techniques that enhance the administration and appropriateness of the intervention program; and examined the effectiveness of this program on quit attempts, quit rates, and overall smoking reduction.

Conditions Studied

Interventions

  • BEHAVIORAL individualized counselor-led MI sessions
  • BEHAVIORAL general health education session
  • BEHAVIORAL NRT

Study Locations (1)

Pennsylvania

  • Center for Asian Health, Lewis Katz School of Medicine, Temple University - Philadelphia

Trial Details

FieldValue
Enrollment Target 139 participants
Start Date 2006-11
Est. Completion 2008-04-30
Phase NA

Sponsor

Temple University

163 total trials

What the Registry Record Tells You About NCT04489524

The ClinicalTrials.gov registry entry for NCT04489524 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (71% lower). The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 3 interventions - of which individualized counselor-led MI sessions is the first listed.

NCT04489524 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04489524 about?

NCT04489524 is a clinical study titled "Smoking Cessation in NYC". The investigators tested the feasibility of a culturally and linguistically sensitive smoking cessation program with combined counseling and pharmacological components for Chinese smokers in New York City; identified factors and techniques that enhance the administration and appropriateness of the i...

What is the current status of trial NCT04489524?

This trial is currently completed. It is a NA study. The enrollment target is 139 participants. The study started on 2006-11. Estimated completion is 2008-04-30.

What conditions does trial NCT04489524 study?

This clinical trial studies the following conditions: Smoking Cessation.

What interventions are being tested in trial NCT04489524?

The interventions under investigation include: individualized counselor-led MI sessions (BEHAVIORAL), general health education session (BEHAVIORAL), NRT (BEHAVIORAL).

Who is sponsoring clinical trial NCT04489524?

This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04489524 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.